CARBOHYDRATE AND LIPID METABOLIC PATHWAYS
碳水化合物和脂质代谢途径
基本信息
- 批准号:2790853
- 负责人:
- 金额:$ 25.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1978
- 资助国家:美国
- 起止时间:1978-05-01 至 1999-01-31
- 项目状态:已结题
- 来源:
- 关键词:carbohydrate metabolism clinical research deuterium deuterium oxide dosage enzyme activity fasting formaldehyde glucokinase gluconeogenesis glucose metabolism glycogen glycogenolysis human subject lipid metabolism liver metabolism magnetic resonance imaging method development noninsulin dependent diabetes mellitus nuclear magnetic resonance spectroscopy obesity pathologic process radiotracer
项目摘要
The long term objective is to develop and apply methods for quantitating
pathways of carbohydrate and lipid metabolism. The specific aim is to
develop a method for estimating rates of gluconeogenesis which is safe,
reliable, definitive, easily performed, and broadly applicable, an apply it
to the testing of hypotheses with regard to carbohydrate metabolism in
physiological and pathological conditions with emphasis on the diabetic
state. D2O is administered at a safe, well tolerated dose. In the fasted
state hexamethylenetetramine, formed from 6 equivalents of formaldehyde, is
used to measure the enrichment of the deuteriums bound to carbons 2,5 and
6 of glucose. Formaldehyde containing the deuterium bound to carbon 6 is
formed on periodic acid oxidation of blood glucose. Formaldehyde
containing deuterium bound to carbon 5 is formed on oxidation of xylose
formed from the glucose. Formaldehyde containing deuterium at carbon 2 is
formed by oxidation of ribitol-5-P formed from the glucose. In the fed
state, the D2O is given with acetaminophen. Deuterium bound to carbon 2
and 5 of glucose formed from the glucuronic acid moiety of the excreted
glucuronide is determined. The fraction of glucose output formed by
gluconeogenesis in the fasted state and the fraction of glycogen formation
by gluconeogenesis in the fed state, also to the ratio of the enrichment at
carbon 5 to that in body water. The carbon 5 to carbon 6 ratio is a
measure of the contribution of glycerol to gluconeogenesis and the extend
of equilibration of the hydrogens of pyruvate with those in water.
Absolute rates of gluconeogenesis in the fasted state are estimated by
multiplying the fraction via gluconeogenesis by glucose output measured
using tritiated glucose or (6,6-D2) glucose. In the fed state the quantity
of glycogen formed is measured using MRI to estimate liver volume and
13CNMR glycogen concentration. In the fasted state MRI and NMR are used to
relate estimates of rates of gluconeogenesis to rates of glycogenolysis.
Measurements will be made in normal subjects, in subjects who are obese and
in NIDDM and MODY subjects.
The findings should bear on the role of the liver in producing
hyperglycemia in the diabetic. This in turn bears on the design of
therapeutic agents and the adequacy of insulin given systemically in
returning metabolism, not just blood glucose concentration, to normal. The
approach for the first time allows the giving of D2O in safe and convenient
doses to obtain adequate labeling in glucose for measurements of the
pathways of its formation and conversion to glycogen. Because of the small
dose of deuterated water that has to be given and the small amount of
glucose that is required for analysis, the approach should be useful in
pediatric as well s adult clinical studies.
长期目标是发展和应用量化的方法
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BERNARD R LANDAU其他文献
BERNARD R LANDAU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BERNARD R LANDAU', 18)}}的其他基金
REGULATION OF CARBOHYDRATE AND LIPID METABOLISM
碳水化合物和脂质代谢的调节
- 批准号:
2292468 - 财政年份:1994
- 资助金额:
$ 25.43万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 25.43万 - 项目类别:
Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 25.43万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 25.43万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 25.43万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 25.43万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 25.43万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 25.43万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 25.43万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 25.43万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 25.43万 - 项目类别:














{{item.name}}会员




